0001140361-24-013627.txt : 20240315 0001140361-24-013627.hdr.sgml : 20240315 20240315201623 ACCESSION NUMBER: 0001140361-24-013627 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240313 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirpekar Sahil CENTRAL INDEX KEY: 0001951712 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 24756636 MAIL ADDRESS: STREET 1: C/O ATAI LIFE SCIENCES N.V. STREET 2: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 form4.xml FORM 4 X0508 4 2024-03-13 0001840904 ATAI Life Sciences N.V. ATAI 0001951712 Kirpekar Sahil WALLSTRASSE 16 BERLIN 2M 10179 GERMANY true Chief Business Officer false Common Shares 2024-03-14 4 M 0 100000 A 100000 D Stock Option 1.84 2024-03-13 4 A 0 550000 0 A 2034-03-13 Common Shares 550000 550000 D Restricted Stock Units 2024-03-14 4 M 0 100000 0 D Common Shares 100000 100000 D Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date. The stock option shall vest as to 25% of the underlying shares on January 1, 2025, and in 36 substantially equal monthly installments thereafter. /s/ Ryan Barrett , Attorney-in-fact 2024-03-15